Valerio Therapeutics (FR0010095596 – ALVIO), a biotechnology company specializing in the development of technology platforms dedicated to the targeted delivery of innovative therapies (the “Company”), ...
Integrant today announced the formal publication of its proprietary “CTC Formula” in Chaos to Creation, (ISBN9798255688227) marking the first time the framework has been made accessible to the public, ...
Almirall team advances small molecule program to preclinical development significantly outperforming standard industry timelinesCollaboration leverages Evotec's end-to-end integrated AI/ML-driven R&D ...
Two River, LLC (“Two River”) and Vida Ventures (“Vida”), both part of the Bellco Health ecosystem, today acknowledged the announced acquisition of Candid Therapeutics (“Candid”), a privately held ...
Deal builds upon UCB’s position as a leader in immunology innovation and expands capabilities in next-generation biologics ...
Opinion
CMS EXPOSED: The "Workaround Doctrine" - How Matt Zorn's Legal CMS Hemp Strategy Undermines the FDA
Matthew C. Zorn previously argued that federal regulators determine "accepted medical use" through the FDA approval framework. Today, he appears on behalf of the United States defending a CMS program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results